A Brief Behavioral Sleep Intervention for Depression Among Military Veterans

April 25, 2018 updated by: Rebecca Ann Bernert, Stanford University
This study investigates the impact of brief behavioral insomnia treatment on depressive symptoms among military veterans.

Study Overview

Study Type

Interventional

Enrollment (Actual)

77

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Palo Alto, California, United States, 94304
        • VA Palo Alto Healthcare System
      • Stanford, California, United States, 94305
        • Stanford University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

  • Age 18 or older
  • Veteran
  • Insomnia Symptoms
  • Depression

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Behavioral Intervention I
This non-medication group treatment (Sleep Intervention I) consists of four 90-minute sessions.
Insomnia-focused behavioral treatment (4 sessions).
Active Comparator: Behavioral Intervention II
This non-medication group treatment (Sleep Intervention II) consists of four 90-minute sessions.
Insomnia-focused behavioral treatment (4 sessions).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Suicidal Ideation
Time Frame: Change from Baseline in Suicidal Ideation at 7 weeks
Change from Baseline in Suicidal Ideation at 7 weeks

Secondary Outcome Measures

Outcome Measure
Time Frame
Insomnia Symptoms
Time Frame: Change from Baseline in Insomnia Symptoms at 7 weeks
Change from Baseline in Insomnia Symptoms at 7 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Rebecca A Bernert, Ph.D., Stanford University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2013

Primary Completion (Actual)

September 1, 2017

Study Completion (Actual)

September 1, 2017

Study Registration Dates

First Submitted

October 7, 2013

First Submitted That Met QC Criteria

October 7, 2013

First Posted (Estimate)

October 9, 2013

Study Record Updates

Last Update Posted (Actual)

April 26, 2018

Last Update Submitted That Met QC Criteria

April 25, 2018

Last Verified

April 1, 2018

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

Clinical Trials on Sleep Intervention I

3
Subscribe